Skip to main content
Top
Published in: Infection 3/2018

01-06-2018 | Original Paper

Notifiable infectious diseases in refugees and asylum seekers: experience from a major reception center in Munich, Germany

Authors: Martin Alberer, Svea Malinowski, Linda Sanftenberg, Jörg Schelling

Published in: Infection | Issue 3/2018

Login to get access

Abstract

Purpose

In 2016, the number of refugees worldwide reached 65.6 million. So far, only limited data are available on the health status of refugees and asylum seekers (RAs). Especially, notifiable infectious diseases (NIDs) carry the risk of outbreaks in communal accommodations hosting RAs.

Methods

We conducted a monocentric retrolective cross-sectional study including 15,137 RAs treated in a special health care unit for RAs located in the major reception center in Munich from November 2014 to October 2016. Altogether 811 RAs with NIDs according to sections 6 and 7 of the German Infection Protection Act or with other infections relevant in the setting of a communal accommodation (RIDs) could be identified.

Results

The gender and age distribution was generally comparable to that of refugees in Germany. However, patients from East Africa and Nigeria were significantly overrepresented. NIDs/RIDs were dominated by cases of tuberculosis, hepatitis B, and vaccine-preventable and parasitic diseases. Significant risk factors included country of origin (COI) and age for hepatitis B, age for hepatitis C, gender and age for HIV, and COI, gender and age for tuberculosis and ectoparasitosis. Calculated prevalences of hepatitis B, hepatitis C, and HIV were mostly below those of the COI. Incidences of tuberculosis were mostly strongly elevated.

Conclusions

COI, gender, and age have an impact on the occurrence of NIDs/RIDs. Early vaccinations and improved hygiene could be effective in preventing NIDs/RIDs in communal accommodations. Screening, prompt therapy, and infection protection measures are necessary to prevent the transmission of diseases.
Literature
4.
go back to reference Bradby H, Humphris R, Newall D, Phillimore J. WHO Health Evidence Network Synthesis Reports. Public Health Aspects of Migrant Health: A Review of the Evidence on Health Status for Refugees and Asylum Seekers in the European Region. Copenhagen: WHO Regional Office for Europe Copyright (c) World Health Organization 2015; 2015. Bradby H, Humphris R, Newall D, Phillimore J. WHO Health Evidence Network Synthesis Reports. Public Health Aspects of Migrant Health: A Review of the Evidence on Health Status for Refugees and Asylum Seekers in the European Region. Copenhagen: WHO Regional Office for Europe Copyright (c) World Health Organization 2015; 2015.
14.
go back to reference Schulz TR, Paxton G, Biggs B-A. Infectious Diseases. In: Loue S, Sajatovic M, editors. Encyclopedia of Immigrant Health. 1st ed. New York: Springer; 2012. p. 902–10.CrossRef Schulz TR, Paxton G, Biggs B-A. Infectious Diseases. In: Loue S, Sajatovic M, editors. Encyclopedia of Immigrant Health. 1st ed. New York: Springer; 2012. p. 902–10.CrossRef
30.
go back to reference Halder G, Kerschel J. Tuberculosis in asylum seekers—data from Munich 2015. Hyg Med. 2016;41:D179–82. Halder G, Kerschel J. Tuberculosis in asylum seekers—data from Munich 2015. Hyg Med. 2016;41:D179–82.
38.
go back to reference Hörmansdorfer S, Ackermann N, Berger A, Bischoff H, Bengs K, Rieder G, et al. Infectiological status of asylum seekers and refugees in Bavaria. Hyg Med. 2016;41:D160–4. Hörmansdorfer S, Ackermann N, Berger A, Bischoff H, Bengs K, Rieder G, et al. Infectiological status of asylum seekers and refugees in Bavaria. Hyg Med. 2016;41:D160–4.
43.
go back to reference Brodhun B, Altmann D, Hauer B, Fiebig L, Haas W. Nationwide analysis in detail. In: Robert Koch Institute, editor. Report on the Epidemiology of Tuberculosis in Germany—2015. Berlin: Robert Koch Institute; 2016. p. 19–63. Brodhun B, Altmann D, Hauer B, Fiebig L, Haas W. Nationwide analysis in detail. In: Robert Koch Institute, editor. Report on the Epidemiology of Tuberculosis in Germany—2015. Berlin: Robert Koch Institute; 2016. p. 19–63.
Metadata
Title
Notifiable infectious diseases in refugees and asylum seekers: experience from a major reception center in Munich, Germany
Authors
Martin Alberer
Svea Malinowski
Linda Sanftenberg
Jörg Schelling
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-018-1134-4

Other articles of this Issue 3/2018

Infection 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.